Vera Therapeutics, Inc. (VERA) stock
Close on Nov 13, 2026Market cap $2.02BP/E –Yield –
Vera Therapeutics statistics
64 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 25, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 6.48
- 2.22
Share statisticsIndustry
- Shares Change (YoY)
- 11.5%
- 10.8%
- Float
- 61M
- 49M
- Shares Held by Insiders
- 14.9%
- 11.7%
- Shares Held by Institutions
- 108.1%
- 56.4%
Short sellingIndustry
- Short Interest
- 12M
- –
- Short Interest Change
- -10.6%
- -0.80%
- Short % of Float
- 19.8%
- 9.01%
- Short % of Shares Outstanding
- 16.8%
- 6.30%
- Days to Cover
- 8.47
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $56.05
- –
- 52-Week Low
- $26.38
- –
- 20-Day Moving Average
- $29.95
- –
- 50-Day Moving Average
- $31.11
- –
- 200-Day Moving Average
- $36.14
- –
- Average True Range (14)
- $1.69
- –
- Price Change (1 Week)
- -5.66%
- -1.15%
- Price Change (1 Month)
- -1.65%
- -4.87%
- Price Change (3 Months)
- -11.2%
- -21.0%
- Price Change (6 Months)
- -24.7%
- -20.6%
- Price Change (YTD)
- -44.5%
- -23.6%
- Price Change (1 Year)
- -9.59%
- -22.4%
- Price Change (3 Years)
- 106.3%
- -29.5%
- Price Change (5 Years)
- 24.8%
- -77.9%
- Average Volume (10 Days)
- 2M
- –
- Average Volume (20 Days)
- 2M
- –
- Average Volume (90 Days)
- 2M
- –
- Relative Volume
- 0.50
- 0.70
- Relative Strength Index (14)
- 41.5
- 43.4
- Volatility (1 Year)
- 58.9%
- 80.1%
- Beta (5 Years)
- 0.83
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -113.5%
- -49.9%
- Return on Assets (ROA)
- -84.5%
- -40.6%
- Return on Capital Employed (ROCE)
- -104.3%
- -37.9%
Financial positionIndustry
- Current Ratio
- 7.91
- 3.30
- Quick Ratio
- 7.10
- 2.39
- Interest Coverage
- -57.40
- -6.35
EfficiencyIndustry
- Profits Per Employee
- -$1.67M
- -$689.41K
- Employee Count
- 249
- 74
- WACC
- 9.24%
- 10.2%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $384.04M
- $17.76M
- Net Cash Per Share
- $5.33
- $0.80
- Equity (Book Value)
- $333.19M
- $53.89M
- Book Value Per Share
- $4.62
- $1.50
- Tangible Book Value
- $312.69M
- $27.13M
- Working Capital
- $385.51M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$125.00K
- -$1.00M
- FCF Per Share
- -$5.22
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -20.5%
- -21.8%
- FCF Yield
- -18.6%
- -9.44%
Taxes and interestIndustry
- Interest Expense
- $7.45M
- $2.90M
Scores and fair valueIndustry
- Altman Z-Score
- 3.87
- 0.23
- Piotroski F-Score
- 2
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | VERA | S&P 500 | Difference | VERA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +4.9% | -3.0% | +7.9 pts | ||
| 3 months | -2.7% | -2.8% | +0.0 pts | ||
| Year to date | -44.5% | +11.5% | −56.0 pts | ||
| 1 year | -1.0% | +13.5% | −14.4 pts | ||
| 3 years | +120.2% | +77.7% | +42.5 pts | +30.1% | +21.1% |
| 5 years | +24.8% | +72.6% | −47.8 pts | +4.5% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
12M VERA shares were sold short on Oct 30, 2026, down 10.6% from the previous report, or 19.80% of the shares available to trade. At recent volumes it would take 8.5 days to buy them back. Over the last 20 sessions, 50.5% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 12,141,556 | -10.6% | 1,433,704 | 8.5 |
| Oct 15, 2026 | 13,587,185 | -21.2% | 1,895,769 | 7.2 |
| Sep 30, 2026 | 17,240,397 | +1.2% | 2,212,016 | 7.8 |
| Sep 15, 2026 | 17,035,040 | -14.3% | 2,755,223 | 6.2 |
| Aug 31, 2026 | 19,873,297 | +18.2% | 1,838,051 | 10.8 |
| Aug 14, 2026 | 16,814,429 | +10.0% | 2,418,287 | 7.0 |
| Jul 31, 2026 | 15,281,960 | +1.3% | 1,621,443 | 9.4 |
| Jul 15, 2026 | 15,081,995 | +11.5% | 3,021,677 | 5.0 |
| Jun 30, 2026 | 13,520,658 | +14.2% | 2,303,446 | 5.9 |
| Jun 15, 2026 | 11,839,194 | +9.3% | 1,138,434 | 10.4 |
| May 29, 2026 | 10,833,205 | +7.5% | 969,229 | 11.2 |
| May 15, 2026 | 10,077,450 | +7.4% | 1,010,135 | 10.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?